Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

This content is for healthcare professionals only.

Please confirm you are a healthcare professional.

Yes
No
TEXAS VIRTUAL MPN WORKSHOP: Module VI

Novel Pathways and Targets in MPNs: Moving Beyond JAKi

Presentations
Myeloproliferative Neoplasms: Context, Pathways and Targets
Alison Moliterno, MD, Johns Hopkins Medicine, Baltimore, MD
28 August, 2020
Targeted Therapies in Combination with JAK Inhibitor
Lucia Masarova, MD, UT MD Anderson Cancer Center, Houston, TX
28 August, 2020
Novel Targeted Therapies Beyond JAK Inhibitors
Naveen Pemmaraju, MD, UT MD Anderson Cancer Center, Houston, TX
28 August, 2020
Previous session View all sessions Next session

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals